ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Sub-Lobar Resection ‘New Standard of Care’ for Small-Sized NSCLC
Friday, August 12, 2022
Submitted by
Source
Source Name: Medwire News
Investigators in the CALGB 140503 recently presented the results of phase 3 of the trial at the IACSLC World Conference on Lung Cancer 2022 in Vienna. The results show that sub-lobar resection is noninferior to lobectomy with respect to disease-free survival and overall survival in patients with clinical stage T1a N0 non-small-cell lung cancer and tumors no larger than 2 cm, among other findings.
Printer-friendly
